Yuan Xu - 03 Aug 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
03 Aug 2021
Transactions value $
$0
Form type
4
Filing time
05 Aug 2021, 16:04:21
Previous filing
03 Jun 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Award $0 +4.74K $0.00 4.74K 03 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +7.5K $0.00 7.5K 03 Aug 2021 Common Stock 7.5K $83.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were granted pursuant to a restricted stock unit award. The units will vest in three annual installments after the grant date, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
F2 The option shall vest in 36 monthly installments after the grant date, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.